4+ hour, 49+ min ago  (213+ words) Solid Q4 results and the FME+ efficiency push keep analysts bullish, even as US dialysis volumes and FX headwinds could slow near-term progress. Fresenius Medical Care says its turnaround is gaining traction, but mwb research argues the real rebound may still…...